Prestige Biopharma Group (Prestige Biopharma / Prestige Biologics)

🚀 We’re excited to share that the 2024 𝐏𝐫𝐞𝐬𝐭𝐢𝐠𝐞 𝐈𝐧𝐭𝐞𝐫𝐧𝐚𝐭𝐢𝐨𝐧𝐚𝐥 𝐒𝐲𝐦𝐩𝐨𝐬𝐢𝐮𝐦 is just around the corner! 🚀 Prestige Biopharma Group's Innovative Discovery Center, the central hub for our R&D activities, is officially opening in Busan, Korea. We invite you to the inaugural symposium at Prestige Biopharma IDC to celebrate this significant milestone. Join us for a remarkable gathering themed “𝘕𝘦𝘸 𝘏𝘰𝘳𝘪𝘻𝘰𝘯𝘴 𝘧𝘰𝘳 𝘉𝘪𝘰𝘱𝘩𝘢𝘳𝘮𝘢𝘤𝘦𝘶𝘵𝘪𝘤𝘢𝘭𝘴: 𝘐𝘯𝘯𝘰𝘷𝘢𝘵𝘪𝘷𝘦 𝘋𝘪𝘴𝘤𝘰𝘷𝘦𝘳𝘺 𝘧𝘰𝘳 𝘓𝘪𝘧𝘦.” This two-day event will feature pioneering strategies, transformative technologies, and open innovation approaches in biopharma development. Don’t miss the chance to engage with global experts, gain valuable insights, and build strong connections within the industry. 👉 For more details and registration, visit: 𝐡𝐭𝐭𝐩://𝐩𝐛𝐩𝐢𝐝𝐜.𝐜𝐨𝐦. Looking forward to seeing you there! 🌍 𝐋𝐨𝐜𝐚𝐭𝐢𝐨𝐧, 𝐃𝐚𝐭𝐞 & 𝐓𝐢𝐦𝐞 📍 𝐕𝐞𝐧𝐮𝐞: ROA Hall, Prestige Biopharma IDC, Busan, Korea 📅 𝐃𝐚𝐭𝐞: November 13 (Wed) – 14 (Thu), 2024 𝐄𝐯𝐞𝐧𝐭 𝐒𝐜𝐡𝐞𝐝𝐮𝐥𝐞 𝐇𝐢𝐠𝐡𝐥𝐢𝐠𝐡𝐭𝐬 📅 𝐃𝐚𝐲 1 (𝐍𝐨𝐯 13) - 13:15: Plenary Lecture on BioEvolution by Prof. Sarfaraz K. Niazi - 14:10: Sessions on Therapeutic Opportunities - 15:35: Sessions on Therapeutic Modality 📅 𝐃𝐚𝐲 2 (𝐍𝐨𝐯 14) - 09:30: Sessions on Open Innovation - 12:00: Panel Talks from Open Innovation industry leaders

✨ Last chance to meet Prestige Biopharma Group at CPHI Worldwide 2024! ✨   As we approach the final day of this exciting event in Milan, don’t miss the opportunity to connect with us before it’s over! Today is your last chance to explore our biosimilar pipelines and discuss our first-in-class antibody drugs. 🌟   We’re also showcasing Prestige Biologics’ CDMO capabilities in single-use biomanufacturing, offering an ideal solution for your antibody drug candidates and various other modalities. 🚀   📍 Booths: No. 24C61, No. 4C82 📅 October 10 (Final day!)   Looking forward to seeing you there!   #PrestigeBiopharma #PrestigeBiologics #Biosimilars #PancreaticCacner #Antibody #CDMO #CMO #CPHI #CPHI2024 #Pharmaceuticals #FieraMilano #Milano

🌱 Prestige Biologics is ready for BIO Japan 2024! From October 9-11, we’ll be in Yokohama, bringing our advanced CDMO solutions to the forefront of the Asian market. With a rising demand for single-use biomanufacturing technologies, we’re excited to connect with key partners in the region and highlight our competitive edge. We aim to provide reliable and efficient CDMO services for companies looking beyond traditional suppliers. 🗺 Location: Pacifico Yokohama 📆 Dates: October 9-11 📍 Booth: No. D-4 Exciting times are ahead as we expand our reach in Asia! 💼 We invite you to visit us at Booth No. D-4! #BIOJapan2024 #PrestigeBiologics #CMO #CDMO #Biomanufacturing #SingleUse #ScaleOut #PacificoYokohama #Yokohama #BIOJapan

✨ Exciting times for Prestige Biopharma Group! We are thrilled to announce our participation in the 2024 CPHI Worldwide exhibition in Milan, Italy, from October 8-10! 🎉 At this event, we look forward to engaging with potential partners regarding the European sales licensing of our newly approved Herceptin biosimilar, Tuznue. We are eager to expand our footprint into Europe and the U.S.! 🤝 We will also highlight our antibody drug for pancreatic cancer, PBP1510, which we expect will attract considerable attention at this gathering. 🌟 Additionally, our CDMO arm, Prestige Biologics, will explore opportunities in single-use biomanufacturing processes, responding to the rising demand for alternatives to the BIOSECURE Act. 🚀 🗺 Location: Fiera Milano 📆 Dates: October 8-10 📍 Booths: No. 24C61, No. 4C82 Our team is committed to securing contract signings and maximizing our CDMO opportunities! Let’s make it happen! 🌟 We invite you to visit us at Booth No. 24C61 and Booth No. 4C82! #PrestigeBiopharma #PrestigeBiologics #Biosimilars #PancreaticCacner #Antibody #CDMO #CMO #CPHI #CPHI2024 #Pharmaceuticals #FieraMilano #Milano

🎉 We're thrilled to share that Prestige Biologics has been recognized as the ‘Best Biologics CMO in South Korea’ at the Biologics Contract Manufacturing Asia 2024! 🏆 This award highlights our outstanding contributions and leadership in the biopharmaceutical industry.   With over a decade of expertise, Prestige Biologics excels in single-use and scale-out biomanufacturing technologies. Our proven success in efficient batch production for major antibody drug projects underscores our commitment to advancing CDMO services with the highest quality and reliability. A huge thank you to our amazing Team Prestige for making this achievement possible! 🙌

We are pleased to announce that Prestige Biopharma’s Herceptin biosimilar, Tuznue®, has received a positive opinion from the EMA’s Committee for Medicinal Products for Human Use (CHMP).   This achievement positions Prestige Biopharma among a distinguished group of global biopharma leaders, having reached this milestone in the EU.   The positive opinion is based on robust Phase III trial data comparing Tuznue®'s efficacy and safety to Herceptin®. Once approved by the European Commission (EC), Tuznue® will be available in 30 European countries.   This is a significant step in our mission to bring Innovation for Life, improving patient lives by increasing access to affordable biosimilars.

We are participating in CPHI China 2024, where over 3,500 companies and institutions have gathered to explore partnering opportunities! 🌟   Prestige Biopharma Group is excited to be part of this dynamic event, connecting with Chinese pharmaceutical companies and innovative biotech startups. We’ve engaged in over 40 meetings to showcase our CDMO business and discuss potential collaborations, and numerous companies have shown great interest in our CDMO facilities and process technology. Let’s make the most of this opportunity to explore partnerships across Prestige Biopharma Group’s full value chain, from cell line development to commercial manufacturing.   We remain available until later this afternoon. Looking forward to connecting with you at CPHI China 📍 Booth # E1B20! 🤝   #CPHIChina #CDMO #CMO #PrestigeBiopharmaGroup #PrestigeBiologics #InnovationForLife

🚀 Excited to share our amazing journey at #BIO2024 in beautiful San Diego! Here's a recap of what we achieved: 🔬 Introduced our group’s first #ADC new drug, 🧬 unveiled our CLD (cell line development) Platform, 💉 showcased the progress of our first-in-class pancreatic cancer treatment, 🤝 had insightful discussions on marketing and sales partnerships for biosimilar pipelines, 💪 explored potential #CDMO partnerships, 🏢 had exciting discussions about an open innovation shared lab, and 💼 held over 100+ meetings inside and outside our booth, connecting with industry leaders and forging valuable relationships. A huge thank you to everyone who made this event a success! Looking forward to bringing Innovation for Life together. #BIOInternationalConvention #PancreaticCancer #PancreaticCancerTreatement #OpenInnovation #CMO #CellLineDevelopment #PrestigeBiopharmaGroup #PrestigeBiopharma #PrestigeBiologics #InnovativeDiscoveryCenter #InnovationForLife

🌟 BIO 2024 has finally begun! If you're in San Diego for BIO 2024, visit us at booth # 5207. Join us to discuss collaboration opportunities with Prestige Biopharma, Prestige Biologics, and IDC (Innovative Discovery Center). We're eager to explore partnerships across the full value chain, from cell line development to commercial manufacturing. Looking forward to connecting with you at the #BIO2024. Don't miss your chance to receive a key ring at 📍 Booth # 5207! #PancreaticCancer #PAUF #CTHRC1 #PancreaticCancerTreatment #OpenInnovation #BioInternationalConvention #CDMO #CMO #PrestigeBiopharmaGroup #PrestigeBiopharma #PrestigeBiologics #InnovativeDiscoveryCenter #InnovationForLife

🌟 Exciting News! Prestige Biopharma Group is heading to #BIO2024! 🌟   We're thrilled to share that Prestige Biopharma Group will be at the Bio International Convention 2024 from June 3rd to 6th in San Diego. This year, we'll be showcasing a joint booth featuring Prestige Biopharma, Prestige Biologics, and IDC (Innovative Discovery Center). Our goal is to explore partnerships across the full value chain, from cell line development to commercial manufacturing.   We'll be highlighting our pancreatic cancer antibody drug PBP1510 and introducing our solid tumor antibody drug PBP1710. We're also exploring collaborations for our new ADC technology and AI-based cancer diagnostic platform.    Additionally, Prestige Biologics is excited to connect with global pharmaceutical and biotech companies to secure CDMO deals. 🌐✨   Visit our booth and show us that you follow Prestige Biopharma Group on LinkedIn to receive a key ring! We can't wait to see you at BIO 2024! 🚀 🚀   🗺 Location: Convention Center San Diego 📆 Dates: June 3-6 📍 Booth : No. 5207   #PancreaticCancer #PAUF #CTHRC1 #PancreaticCancerTreatment #OpenInnovation #BioInternationalConvention #CDMO #CMO #PrestigeBiopharmaGroup #PrestigeBiopharma #PrestigeBiologics #InnovativeDiscoveryCenter #InnovationForLife